Literature DB >> 26164835

Cross-Cultural Adaptation of the Urticaria Control Test From German to Castilian Spanish.

I García-Díez1, L Curto-Barredo2, K Weller3, R M Pujol2, M Maurer3, A M Giménez-Arnau2.   

Abstract

INTRODUCTION: The clinical concept of urticaria embraces a heterogeneous group of conditions classified according to their clinical course as acute (lasting less than 6 weeks) or chronic (lasting 6 weeks or more). Chronic urticaria may be either spontaneous or induced. Few tools are available for monitoring the various clinical forms of this disease or for evaluating its impact on quality of life. The recently developed Urticaria Control Test to evaluate disease control is available in German, the original language, and American English.
OBJECTIVE: To culturally adapt the long and short versions of the Urticaria Control Test to Castilian Spanish to ensure equivalence between the translated items and those of the original version.
MATERIAL AND METHODS: To translate the Urticaria Control Test we followed the International Society for Pharmacoeconomics and Outcomes Research good practice guidelines, starting with forward translation and moving through back translation and cognitive debriefing steps.
RESULTS: Three items were modified when the first Spanish version, translated from German, was discussed (cognitive debriefing). The revised translation was then translated back to German and sent to the Urticaria Control Test authors, who modified one item they considered had acquired a different focus through translation. A third Spanish version was then prepared and after minor proofreading changes was considered definitive.
CONCLUSIONS: This study was the first step in making it possible to use the Urticaria Control Test questionnaire in Castilian Spanish. The next step will be to validate the translated questionnaire.
Copyright © 2015 Elsevier España, S.L.U. and AEDV. All rights reserved.

Entities:  

Keywords:  Adaptación transcultural; Cognitive debriefing; Cross-cultural adaptation; Cuestionarios; Entrevistas cognitivas; Questionnaires; Urticaria; Urticaria Control Test

Mesh:

Year:  2015        PMID: 26164835     DOI: 10.1016/j.ad.2015.05.009

Source DB:  PubMed          Journal:  Actas Dermosifiliogr        ISSN: 0001-7310


  6 in total

1.  The Burden on Cohabitants of Patients with Chronic Spontaneous Urticaria: A Cross-Sectional Study.

Authors:  Manuel Sánchez-Díaz; Maria-Carmen Salazar-Nievas; Alejandro Molina-Leyva; Salvador Arias-Santiago
Journal:  J Clin Med       Date:  2022-06-06       Impact factor: 4.964

2.  Chronic urticaria in most patients is poorly controlled. Results of the development, validation, and real life application of the arabic urticaria control test.

Authors:  Carla Irani; Souheil Hallit; Karsten Weller; Marcus Maurer; Carla El Haber; Pascale Salameh
Journal:  Saudi Med J       Date:  2017-12       Impact factor: 1.484

Review 3.  Disease Severity, Activity, Impact, and Control and How to Assess Them in Patients with Hereditary Angioedema.

Authors:  Anette Bygum; Paula Busse; Teresa Caballero; Marcus Maurer
Journal:  Front Med (Lausanne)       Date:  2017-12-04

4.  Adaptation and Validation of the Korean Version of the Urticaria Control Test and Its Correlation With Salivary Cortisone.

Authors:  Ji Ho Lee; Yoon Ju Bae; So Hee Lee; Su Chin Kim; Hyun Young Lee; Ga Young Ban; Yoo Seob Shin; Hae Sim Park; Juergen Kratzsch; Young Min Ye
Journal:  Allergy Asthma Immunol Res       Date:  2019-01       Impact factor: 5.764

5.  Chronic spontaneous urticaria activity, impact and control as well as their changes are strongly linked, and these links are not affected by angioedema or comorbid inducible urticaria - Results from the validation of the Polish Urticaria Control Test.

Authors:  Zenon Brzoza; Karina Badura-Brzoza; Marcus Maurer; Tomasz Hawro; Karsten Weller
Journal:  World Allergy Organ J       Date:  2022-03-21       Impact factor: 4.084

6.  Patient-reported outcomes in urticarial vasculitis treated with omalizumab: case report.

Authors:  Ivan Cherrez-Ojeda; Emanuel Vanegas; Miguel Felix; Valeria L Mata; Annia Cherrez
Journal:  BMC Dermatol       Date:  2018-10-25
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.